These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3485660)

  • 1. Pathophysiology of hemolysis in infections with Hemophilus influenzae type b.
    Shurin SB; Anderson P; Zollinger J; Rathbun RK
    J Clin Invest; 1986 Apr; 77(4):1340-8. PubMed ID: 3485660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.
    Schneerson R; Rodrigues LP; Parke JC; Robbins JB
    J Immunol; 1971 Oct; 107(4):1081-9. PubMed ID: 5315273
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.
    Shah TA; Mauriello CT; Hair PS; Sharp JA; Kumar PS; Lattanzio FA; Werner AL; Whitley PH; Maes LA; Cunnion KM; Krishna NK
    Transfusion; 2014 Nov; 54(11):2892-900. PubMed ID: 24806146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human serum activities against Hemophilus influenzae, type b.
    Anderson P; Johnston RB; Smith DH
    J Clin Invest; 1972 Jan; 51(1):31-8. PubMed ID: 4536614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hemolytic anemia due to cold agglutinins. II. The role of C' in red cell destruction.
    Evans RS; Turner E; Bingham M; Woods R
    J Clin Invest; 1968 Apr; 47(4):691-701. PubMed ID: 5641611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Jun; 53(6):1742-9. PubMed ID: 4598114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):575-82. PubMed ID: 4536807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of crossreactive idiotypes by human antibodies specific for the capsular polysaccharide of Hemophilus influenzae B.
    Lucas AH
    J Clin Invest; 1988 Feb; 81(2):480-6. PubMed ID: 3257499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the capsular polysaccharide of Haemophilus influenzae type B with C1q.
    Bunse R; Heinz HP
    Behring Inst Mitt; 1993 Dec; (93):148-64. PubMed ID: 8172562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of splenic congestion associated with hemolytic anemia on mortality of rats challenged with Haemophilus influenzae b.
    Chen LT; Moxon ER
    Am J Hematol; 1983 Sep; 15(2):117-21. PubMed ID: 6604453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of Haemophilus influenzae serotype b capsular polysaccharide antigen in body fluids by enzyme immunoassay.
    Henne G; Tiller FW; Diener E
    Biomed Biochim Acta; 1984; 43(3):381-7. PubMed ID: 6378194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of chemotactic activity in serum by Haemophilus influenzae type b.
    Tosi MF; Kaplan SL; Mason EO; Buffone GJ; Anderson DC
    Infect Immun; 1984 Feb; 43(2):593-9. PubMed ID: 6607218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms.
    Clark DA; Dessypris EN; Jenkins DE; Krantz SB
    Blood; 1984 Nov; 64(5):1000-5. PubMed ID: 6386071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type-specific capsular carbohydrate of Hemophilus influenzae B is a potent mitogen for murine B lymphocytes.
    Lucas AH; Asser SM
    J Immunol; 1986 Nov; 137(10):3130-4. PubMed ID: 3490510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical manifestations, diagnosis and treatment of Haemophilus influenzae infection].
    Bachiller Luque P; Eiros Bouza JM; Blanco Quirós A
    An Med Interna; 2000 Apr; 17(4):204-12. PubMed ID: 10893774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
    Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
    Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.